Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]

Spot Biosystems has emerged from stealth with $40 million in [...]

Tevard Biosciences has presented new preclinical data demonstrating the potential [...]

CureDuchenne will host CureDuchenne Fuerza 2025, a one-day educational and [...]

Renowned neuromuscular clinician and researcher to shape care strategies and [...]

A new partnership aims to change the game in gene [...]